“…Implanted biomaterials frequently trigger inflammatory responses which may, in turn, presage serious iatrogenic consequences such as stress cracking of pacemaker leads (1,2), osteolysis adjacent artificial joints (3)(4)(5), and fibrosis and capsule contracture affecting mammary prostheses (6)(7)(8)(9)(10). The causes of these adverse responses are still obscure, particularly in view of the nontoxic, nonimmunogenic, and chemically inert nature of most implantable biomaterials.…”
The frequent inflammatory responses to implanted medical devices are puzzling in view of the inert and nontoxic nature of most biomaterials. Because implant surfaces spontaneously adsorb host proteins, this proteinaceous film is probably important in the subsequent attraction of phagocytes. In fact, earlier we found that acute inflammatory responses to experimental polyethylene terephthalate implants in mice require the precedent adsorption of one particular host protein, fibrinogen. The present investigations were aimed at defining the molecular determinants of fibrinogen-mediated acute inflammatory responses to implanted biomaterials. We find: ( a ) plasmin degradation of purified fibrinogen into defined domains reveals that the proinflammatory activity resides within the D fragment, which contains neither the fibrin cross-linking sites nor RGD sequences; ( b ) the major (and, perhaps, exclusive) proinflammatory sequence appears to be fibrinogen ␥ 190-202, previously shown to interact with CD11b/CD18 (Mac-1). The chemically synthesized peptide, cross-linked to albumin (which itself does not promote inflammatory responses), mimics the proinflammatory effect of adsorbed native fibrinogen; and ( c ) this sequence probably promotes inflammatory responses through interactions with Mac-1 because phagocyte accumulation on experimental implants is almost completely abrogated by administration of recombinant neutrophil inhibitory factor (which blocks CD11b-fibrin(ogen) interaction). We conclude that improved knowledge of such surface-proteinphagocyte interactions may permit the future development of more biocompatible implantable materials. ( J. Clin. Invest. 1996. 97:1329-1334.)
“…Implanted biomaterials frequently trigger inflammatory responses which may, in turn, presage serious iatrogenic consequences such as stress cracking of pacemaker leads (1,2), osteolysis adjacent artificial joints (3)(4)(5), and fibrosis and capsule contracture affecting mammary prostheses (6)(7)(8)(9)(10). The causes of these adverse responses are still obscure, particularly in view of the nontoxic, nonimmunogenic, and chemically inert nature of most implantable biomaterials.…”
The frequent inflammatory responses to implanted medical devices are puzzling in view of the inert and nontoxic nature of most biomaterials. Because implant surfaces spontaneously adsorb host proteins, this proteinaceous film is probably important in the subsequent attraction of phagocytes. In fact, earlier we found that acute inflammatory responses to experimental polyethylene terephthalate implants in mice require the precedent adsorption of one particular host protein, fibrinogen. The present investigations were aimed at defining the molecular determinants of fibrinogen-mediated acute inflammatory responses to implanted biomaterials. We find: ( a ) plasmin degradation of purified fibrinogen into defined domains reveals that the proinflammatory activity resides within the D fragment, which contains neither the fibrin cross-linking sites nor RGD sequences; ( b ) the major (and, perhaps, exclusive) proinflammatory sequence appears to be fibrinogen ␥ 190-202, previously shown to interact with CD11b/CD18 (Mac-1). The chemically synthesized peptide, cross-linked to albumin (which itself does not promote inflammatory responses), mimics the proinflammatory effect of adsorbed native fibrinogen; and ( c ) this sequence probably promotes inflammatory responses through interactions with Mac-1 because phagocyte accumulation on experimental implants is almost completely abrogated by administration of recombinant neutrophil inhibitory factor (which blocks CD11b-fibrin(ogen) interaction). We conclude that improved knowledge of such surface-proteinphagocyte interactions may permit the future development of more biocompatible implantable materials. ( J. Clin. Invest. 1996. 97:1329-1334.)
“…The suspicion of the material being silicone was confirmed by identifying silicium in the pseudocapsule [9,13,15]. Some authors believed that these particles were fragments broken offthe surface of the silicone shell [2,5,9,12,14] with which we agree. However, this does not explain why the pseudocapsules forming around saline-filled implants were generally found to be thinner than those forming around gel-filled silicone implants, although both types of implants have an almost identical silicone shell.…”
mentioning
confidence: 87%
“…Subsequently it was felt that the transgressed liquid silicone was responsible for the contamination of the pseudocapsule [2,5,9,12]. Barker et al [2] and Bergman and van der Ende [3] showed in an in vitro study that the gel-filled implants leaked liquid silicone.…”
In 2,000 patients who underwent augmentation mammoplasties with different types of prostheses, the thickness of the pseudocapsules around gel-filled implants was greater than that of the pseudocapsules forming around inflatable implants. This observation was corroborated by an independent histologic study. Deposition of liquid silicone into the pseudo-capsules as well as the adjacent breast tissue and migration into capillaries was demonstrated. Until an impermeable shell or a non-transgressive gel can be manufactured, gel-filled implants should not be used.
“…Researchers have demonstrated fairly imequivocally that silicone can leak out of an mtact implant (Brandt et al 1984, Wmgdmg et al 1988 Thomsen et al (1990) con-cluded m their study that leaked silicone caused an inflammatory response withm the tireast capsule Moreover, Smahel (1979) found strong evidence that sihcone particles could reach the lumen of blood vessels in a vanety of ways, thus explainmg the route by which silicone could be earned to other parts of the body Recent reports surest that this may be an issue of some concem Silicone prostheses tiave been strongly linked to the development of human adjuvant disease (HAD), a connective tissue-type disease with a wide vanety of symptoms, including skin tightenmg or thickening and hair loss on the extremities, migratory arthralgias and arttintis (Brozena et al 1988, Sahn et al 1990 This problem appears to be relatively rare, and its low incidence makes it difficult to draw firm conclusions about a casual relationship with implants One group of researchers (Weisman et al 1988) looked for scleroderma-type s}Tnptoms in 125 women with silicone implants and found none, they concluded that 'it does not appear likely that augmentation mammaplasty is a significant or major lnducer of inflammatory connective-tissue diseases m general' They noted, however, that in view of the small sample size, their findings must be considered preliminary Part of the problem in studying HAD is that symptoms are varied and often vague, suggesting that the disease may go undiagnosed As well, in the reported case studies (Brozena et al 1988, Sahn et al 1990, the patients had all had their implants many years tiefore, so it is difficult to make a causal link to the implant However, the fact that removal of the implants resulted in immediate reversal of symptoms is fairly suggestive Rupture Not only does silicone leak out of intact implants, but implants may also mpture According to van Rappard et al (1988), implant ruptures occur in 1% of all augmentation mammaplasties These researchers demonstrated that the pressure generated in closed capsulotomy is sufficient to rupture a senous proportion of implants, and that the older the implant, the less pressure required to break it Of significant concem is the fact that capsular rupture often goes undetected Diagnosis by physical examination IS difficult, as the S5rmptoms can be vague and radiographic reports inconclusive (Theophelis & Stevenson 1986, Andersen et al 1989 Some physical symptoms of implant rupture mclude nodules, decreased breast size, asymmetry, tenderness and a softer texture (Anderson et al 1989) The woman who has undergone a closed capsulotomy should he particularly vigilant m watchmg for such signs It should also t>e noted that breast augments present special problems for mammographers, so it is important that a woman v«th implants seek a facility where the technologist and radiologist have expenence m visualizing the augmented breast…”
Surgery to increase breast size is a common procedure. In this paper we examine the reasons why women choose to undergo the procedure, the history of breast enhancement, current surgical approaches, possible complications and their treatment. Driving forces behind the choice to have augmentation surgery appear to be related to feelings of low self-esteem and self-confidence. Although there is a large literature related to breast augmentation, little of it is research-based. The research that there is focuses on complications and their treatment, with an emphasis on capsular contracture. Few of the studies are long-term, although complications have been noted as long as 25 years after initial implantation. There is a need for research into the experience of women undergoing augmentation mammaplasty but, perhaps more importantly, there is also a need to examine ways in which women can be helped to accept themselves as they are.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.